Skip to Content

User Reviews for Propulsid

The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Condition	Avg. Ratings		Reviews	Compare
GERD	1.0		1 review	222 medications

Reviews for Propulsid

For GERD "This drug is no longer available in the United States."

1.0

Anonymous March 10, 2009

5 users found this comment helpful.
Did you? Yes No | Report inappropriate

Learn more about

Micromedex® Care Notes

Indigestion

Mayo Clinic Reference

Indigestion

More about Propulsid (cisapride)

Consumer resources

Professional resources

Propulsid (FDA)

Related treatment guides

Drug Status

Availability Discontinued

Pregnancy & Lactation Risk data available

CSA Schedule* Not a controlled drug

Approval History Drug history at FDA

Ulcerative Colitis (MS)

Drug Class

Related Drugs

Gastroparesis metoclopramide, Reglan, cisapride, Metozolv ODT, More...

GERD omeprazole, ranitidine, pantoprazole, famotidine, Protonix, Nexium, Prilosec, Zantac, More...

Indigestion omeprazole, ranitidine, famotidine, Prilosec, Zantac, Pepcid, calcium carbonate, magnesium oxide, More...

Propulsid Images

Pill Imprint JANSSEN P 10 (Propulsid 10 mg)

Propulsid 10 mg (JANSSEN P 10)

View larger images

Get Email Updates

Subscribe to free Drugs.com newsletters.

By clicking Subscribe, I agree to the Drugs.com Terms & Conditions & Privacy Policy and understand that I may opt out of Drugs.com subscriptions at any time.

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 4th, 2018), Cerner Multum™ (updated Sep 4th, 2018), Wolters Kluwer™ (updated Sep 3rd, 2018) and others. To view content sources and attributions, please refer to our editorial policy.